secwatch.observer — SEC 8-K summary
======================================

Issuer:     Finch Therapeutics Group, Inc. (FNCHQ)
CIK:        0001733257
Form:       8-K
Filed at:   2024-08-12T23:59:59+00:00
Accession:  0001193125-24-198362
Event type: litigation
Sentiment:  positive
Materiality: 0.85
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Jury awards Finch $25M upfront plus royalties in patent infringement verdict against Ferring
--------------------------------------------------------------------------------

- Jury found Ferring willfully infringed on Finch/UMN patents for microbiome therapy Rebyota.
- Damages include $25.0M upfront payment and $0.815M in running royalties through trial date.
- Two claims (one from '309, one from '080 patents) were found invalid; remaining claims valid.
- Finch expects Ferring to file post-trial motions and appeal the judgment.
- Trial began Aug 5, 2024; verdict rendered Aug 9, 2024 in U.S. District Court for Delaware.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524198362/0001193125-24-198362-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1733257/000119312524198362/d801504d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-198362

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer